Treatment of T-Cell Prolymphocytic Leukemia with Central Nervous System Involvement Using Intrathecal Alemtuzumab Administration
T-cell prolymphocytic leukemia (T-PLL) is a rare hematologic cancer with a dismal prognosis. Although a small number of patients have central nervous system (CNS) involvement, a standard treatment approach for these patients has not been established. Herein, we present a case of T-PLL with CNS invol...
Saved in:
| Main Authors: | Jinichi Mori, Kumi Oshima, Satoshi Kimura, Takayuki Ikezoe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2020/8822172 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-cell prolymphocytic leukemia, cerebriform variant
by: Daniel Mazza Matos
Published: (2024-12-01) -
Alemtuzumab in treatment of chronic lymphocytic leukemia
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse
by: Elan Gorshein, et al.
Published: (2018-01-01) -
Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia
by: Marta Brunetti, et al.
Published: (2025-08-01) -
Use of Campath-1H in T-cell prolymphocytic leukemia (case report and review of literature)
by: V. A. Doronin, et al.
Published: (2022-11-01)